Disorder-specific impaired neurocognitive function in major depression and generalized anxiety disorder

Wei Luo,Lizhu Luo,Qiang Wang,Yunge Li,Yamin Zhang,Yalan Hu,Yue Yu,Shu Yu,Fengmei Lu,Jiajia Chen,Li Liu,Na Du,Christelle Langley,Zongling He,Tao Li,Barbara J. Sahakian
DOI: https://doi.org/10.1016/j.jad.2022.08.129
IF: 6.533
2022-12-01
Journal of Affective Disorders
Abstract:BackgroundGeneralized anxiety disorder (GAD) and major depressive disorder (MDD) are both highly prevalent and comorbid psychiatric disorders. Neurocognitive dysfunction has been commonly found in MDD, but the findings in GAD are inconsistent. Few studies have directly compared cognitive performance between GAD and MDD. Therefore, the present study aimed to reveal the similar and distinct cognitive impairments between both disorders.MethodsThree non-overlapping and non-comorbid groups were enrolled in the current study including patients with GAD (n = 37), MDD (n = 107) and healthy controls (n = 74). Levels of anxiety and depression were assessed using the Hamilton Anxiety Rating Scale (HAMA) and the Hamilton Depression Rating Scale (HAMD) respectively. The Cambridge Neuropsychological Test Automated Battery (CANTAB) was used to compare the cognitive performance, including sustained attention, visual memory, executive functions and learning.ResultsBoth MDD and GAD groups demonstrated common significant deficits in sustained attention, visual memory, working memory and learning when compared to healthy controls. Despite the similarities, the MDD group had significantly greater impairment in learning, particularly generalization, while the GAD group demonstrated more pronounced deficits in visual memory.LimitationsPatients involved were medicated and the sample size for GAD was relatively small.ConclusionsThe significant differences in visual memory and learning between MDD and GAD groups might be indicators to distinguishing both disorders. These results confirm that cognitive function is of great importance as a future target for treatment in order to improve wellbeing, quality of life and functionality in both GAD and MDD.
psychiatry,clinical neurology
What problem does this paper attempt to address?